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Abstract
Background: The appearance of ST-segment elevation (STE) and pathological Q wave were signs of worse myocardial damage and 
function, the quantitative measurement of the waves have a potential prognosis role. This study assesses the performance of the 
quantitative measurement of the waves in predicting in-hospital mortality and compares it with the Global Registry of Acute Coronary 
Events (GRACE) score as the standard recommended risk score.
Methods: This was a cross-sectional study included patients with ST-elevation myocardial infarction (STEMI) that hospitalized in Abdul 
Wahab Sjahranie General Hospital Samarinda during January to December 2016. Standard 12-lead electrocardiograms (ECG) were 
assessed at patient admission as well as other data for GRACE score. The subjects were grouped into non-survivor and survivor group 
based on hospitalization survival state, and six quantitative ECG characteristics performance will be assessed. The performances were 
assessed using receiver operating characteristics (ROC) curve and area under the curve (AUC).
Results: There were 57 subjects consisting of 9 non-survivor subjects. The AUC of the four ECG characteristics highest STE amplitude, 
deepest Q amplitude, total Q amplitude, and total STE amplitude did not significantly different with GRACE score (p>0.05). Highest 
STE amplitude has the best performance than the other ECG characteristics (AUC=0.81, 95% CI:0.65 to 0.97), and cut off point 
4.5mm provides 56% sensitivity and 94% specificity.
Conclusion: The quantitative measurement of ST-segment deviation and pathological Q wave have the prognosis role for predicting 
in-hospital mortality.
(Indonesian J Cardiol. 2019;40:275-281)
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Introduction
ST-elevation myocardial infarction (STEMI) is one of the acute coronary syndrome (ACS) spectrum identified by the presence of the myocardial ischemia symptom, and persistent 
ST-segment elevation (STE).1 The mortality of this ACS 
type is higher than the other type.2,3 Most of this type 
will be evolved into Q wave myocardial infarction by 
the presence of pathological Q wave.2,4
 Ischemic risk assessment is recommended for a 
patient with acute myocardial infarction (AMI), not only 
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for prognosis assessment but also help to determine the 
treatment strategy.1,5 Global Registry of Acute Coronary 
Events (GRACE) score is one of risk stratification score 
that can estimate mortality in hospital, at 6 months, 1 
year, and 3 years, European Society of Cardiology (ESC) 
recommends the use of this risk score for the patient 
with AMI, include STEMI patient.1,5
 The appearance of STE and pathological Q wave 
were signs of worse myocardial damage and function. 
On electrophysiological perspective, STE is a sign of the 
electrical shift of ST-segment because of abnormality of 
K+ channel result from transmural myocardial ischemia, 
while the pathological Q waves are signs of the electrical 
window, an area that severely electrically impaired, 
ranging from hibernating, stunning, and necrosis of 
myocardium.6-9
 Our hypotheses are the characteristics and magnitude 
of the STE and pathological Q wave have prognostic 
a role. In this study, we determine the quantitative 
measurement of STE and pathological Q wave and its 
performance in predicting the in-hospital mortality and 
compare it with GRACE score as the standard risk score 
for STEMI.
Methods
The subjects were STEMI patients who were treated 
in period January to December 2016 in the Abdul 
Wahab Sjahranie General Hospital in Samarinda, East 
Kalimantan. ESC criteria for STEMI were used to 
define the STEMI diagnosis. STEMI was defined by 
the presence of symptom consistent with myocardial 
ischemia (eg. persistent chest pain) and ECG sign 
that meets the STEMI criteria, ST-segment elevation 
(measured using J-point, and two consecutive PR 
interval as a baseline), at two or more contiguous leads 
with elevation ≥2.5mm in men <40 years, ≥2.0mm 
in men >40 years, or ≥1.5mm in the woman in leads 
V2-V3 and/or ≥1mm in other leads. Standard 12-lead 
ECG calibration 10mm/mV and 25mm/s were used 
in this study. Standard treatment such as thrombolytic, 
anticoagulant, antiplatelet, and other medications are 
used as indicated.
 The subjects were grouped into a non-survivor 
and survivor group based on the survival state during 
hospitalization. The ECG characteristics and GRACE 
score are compared between the group, and the 
performance of these variables to predict mortality will 
also be analyzed. Exclusion criteria are subject with a 
history of AMI, poor quality ECG and/or with QRS 
confounders (e.g. left bundle branch block).
 There are six ECG characteristics included as 
variables in this study. The definitions of the variables 
are shown in table 1. Pathological Q waves are defined 
as Q-wave with a duration of ≥40 ms and/or a depth 
≥25% of the R-wave in the same lead, that present in 
two or more contiguous leads. The ECG characteristics 
were measured by a physician manually based on the 
ECG criteria. GRACE score is obtained by calculating 
the characteristics of the subject that include the age, 
heart rate, systolic blood pressure, creatinine level, Killip 
class, cardiac arrest at admission, ST-segment deviation, 
and cardiac enzymes. All of the ECG characteristics and 
data to determine the GRACE score are obtained from 
the medical record at the time of patient admission. 
 Kolmogorov-Smirnov test was used to asses the 
normality distribution of the data. Variables with 
continuous type were presented as mean and standard 
deviations for data that normally distributed, or median 
(25th percentile, 75th percentile) for data that not 
normally distributed. Variables with categorical type 
were presented as an absolute number with a percentage. 
Independent T-test or Mann-Whitney test was used to 
compare the continuous variables that depend on the 
distribution of the data, while the Chi-Square test or 
Fisher exact test was used to compare noncontinuous 
variables. The performance of the diagnostic value of 
ECG characteristics and GRACE score to predict in-
hospital mortality were assessed using receiver operating 
characteristic (ROC) curve and area under the curve 
(AUC). Statistical significance is obtained when P<0.05. 
All analyses were done using IBM SPSS statistics version 
19, except for comparison (c-statistic) of the ROC 
curve and AUC (DeLong method) that using Medcalc 
statistical software version 18.6.
Results 
A total of 57 subjects were included in this study. There 
were 9 non-survivor subjects during hospitalization, 
they had higher Killip class and troponin-T value on 
admission than survivor subjects. The characteristics of 
the subject are shown in table 2. 
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ST-segment deviation
Table 3 shows the result of Mann-Whitney test of the 
ST-segment deviation characteristics.  The maximum 
value of highest STE amplitude of the non-survivor 
and survivor group were 9mm and 6mm respectively, 
while maximum number involved lead with STE and 
maximum total STE amplitude in the non-survivor 
group were 8 leads and 28mm, and 6 leads and 27mm 
in the survivor group.
Pathological Q wave
The non-survivor group had the maximum value 
of deepest Q amplitude and the maximum value of 
number involved lead 4mm and 5 leads, respectively, as 
well as survivor group. The maximum value of the total 
Q amplitude in the non-survivor group was 13mm, and 
10mm in the survivor group. The results of the Mann-
Whitney test of the pathological Q wave characteristics 
are shown in table 3.
GRACE score
The median of GRACE score in this study was 138. 
The non-survivor group had higher GRACE score than 
the survivor group (207(150, 227) and 133(113, 150), 
p=0.001) using the Mann-Whitney test. The highest 
and lowest GRACE score in the non-survivor group 
were 257 and 155, and in the survivor group 200 and 
89, respectively.
ECG characteristics and GRACE score perfor-
mance 
The performance of the ECG characteristics and 
GRACE score in predicting the in-hospital mortality 
are shown in figure 1. Highest STE amplitude had the 
best performance than the other ECG characteristics 
(AUC=0.81, 95% CI:0.65 to 0.97), cut off point of 
highest STE amplitude 3.5mm had 78% sensitivity 
and 65% specificity, and cut off point 4.5mm had 56% 
sensitivity and 94% specificity. Highest STE amplitude, 
deepest Q amplitude, total Q amplitude, and total STE 
amplitude were not significantly different with GRACE 
score in predicting in-hospital mortality using DeLong 
method for AUC and standard error comparison 
(table4). 
Discussion
The ECG characteristics have the prognostic 
information in STEMI patients and help identification 
of group who will have benefit with more aggressive 
intervention.10,11 In this study we found that ECG 
characteristics had comparable performance to GRACE 
score. The performance of the four ECG characteristics 
highest STE amplitude, deepest Q amplitude, total 
Q amplitude, and total STE amplitude had similar 
performance with GRACE score in predicting the in-
hospital mortality. The highest STE amplitude had the 
best performance than the other ECG characteristics. 
Different from the previous studies, in this study, we 
focused on the quantitative measurement of the wave, 
that is using a numeric scale for the amplitude of the 
waves, and we compare the performance of the multiple 
Table 1. Operational definitions of the Electrocardiogram 
(ECG) characteristics
Definition
Number lead with STE The number of lead in standard 
12-lead ECG that contains the ST-
segment elevation.
Highest STE amplitude The highest/maximum deviation 
of the ST-segment elevation in 
standard 12-lead ECG. The degree 
of elevation is measured at J-point 
of the highest ST-elevation and 
presented as mm.
Total STE amplitude The sum of all ST-segment 
elevation amplitude in all lead that 
contains ST-segment elevation 
in standard 12-lead ECG. The 
degree of elevation is measured at 
J-point in all lead that contains ST-
segment elevation and presented 
as mm.
Number lead with Q The number of lead in standard 
12-lead ECG that contains the 
pathological Q wave.
Deepest Q amplitude The deepest/maximum amplitude 
of the Q wave in standard 12-lead 
ECG. The degree of amplitude is 
presented as mm.
Total Q amplitude The sum of all Q wave amplitude 
in all lead that contains 
pathological Q wave in standard 
12-lead ECG. The degree of 
amplitude is presented as mm.
STE=ST-segment elevation
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ECG parameter (ST-deviation and pathological Q 
wave characteristics), also comparing with the standard 
ischemic risk score, GRACE score.
 During the progression of the STEMI, there are 
changes in the characteristic of ECG, the high-grade 
ischemia (grade 3 from three classifications of the 
ischemia) has STE with distortion of the QRS terminal 
(no S wave in leads with usual Rs configuration or J 
point/R  wave ratio ≥ 0.5 in leads with usual qR 
configuration) reflecting the higher STE the higher 
grade of ischemia.12 The terminal QRS distortion 
in high-grade ischemia reflects the prolongation of 
Purkinje fibers in the ischemic region and reflects the 
worse ischemia and prognosis.12 
 A study from De Luca et al. using residual STE 
after primary percutaneous coronary intervention (PCI) 
shows that cumulative ST-segment deviation was an 
independent predictor of 1-year mortality (RR=1.31, 
95% CI: 1.06 to 1.63, p=0.014).13 Cumulative STE has 
better performance (AUC=0.733) than STE resolution 
(AUC=0.636) or ST-segment deviation resolution 
(AUC=0.660) in predicting 1-year mortality.13 In 
another study using ST-segment deviation in the ECG 
lead that contains maximum STE after thrombolysis, 
the performances were AUC=0.761 for 90 minutes 
after thrombolysis, and AUC=0.755 after 180 minutes 
after thrombolysis for predicting 30-day mortality, these 
performances were better than the performance of sum 
of STE resolution and STE resolution in only the one 
lead showing the maximal deviation.14
 The maximum STE also has better performance 
than the sum of STE resolution for predicting 180-day 
mortality (AUC 0.680 vs 0.622).15 Our study using 
the ECG that immediately measured when the patient 
on admission, the maximum magnitude of the STE 
also shows the best performance than the sum/total 
STE amplitude, and with better performance than the 
previous studies, and comparable with GRACE score.
 Maximum residual STE magnitude provides 
prognostic information about another adverse event 
such as heart failure and shock but still better predicting 
the 90-day mortality (AUC=0.802 vs AUC=0.832).16 A 
study shows that a higher magnitude of STE associated 
with more total occlusion, less collateral circulation, 
lower left ventricular ejection fraction (LVEF) and 
higher infarct size.17 These parameters are known as the 
predictor of prognosis in patient with AMI.
Table 2. Subject characteristics
Characteristics Non-survivor(n=9)
Survivor
(n=48)
Age, years* 57±9 56±10
Men, n(%) 7(78) 41(85)
History, n(%)
   Diabetes mellitus
   Hypertension
5(55)
4(44)
13(27)
20(42)
Heart rate, bpm† 102(71, 117) 80(66, 89)
Systolic blood pressure, 
mmHg†
120(80, 130) 130(120, 140)
Diastolic blood pressure, 
mmHg†
70(U, 80) 80(76, 90)
Respiration rate, bpm† 26(24, 30) 22(20, 26)
Killip class† 3(1, 4) 1(1, 1)
Ureum, mg/dl† 38(31, 42) 35(28, 45)
Creatinine, mg/dl† 1.2(0.9, 1.5) 1(0.8, 1.4)
Troponin-T on 
admission, ng/L †
882(298, 1950) 138(75,1198)
 U=Undetected; *mean±standard deviation; †median(25th 
percentile, 75th percentile)
 
 Prognostic role of the appearance pathological 
Q wave was known since years ago, but quantitative 
measurement and its relation to the degree of adverse 
event and cardiac performance still challenging. The 
sum of pathological amplitude is correlated with infarct 
size and cardiac function in the animal model.18  The 
appearance of the wave also reflects the worst ventricular 
function in the human subject.19 Another study shows 
that state of hibernation, stunning and/or necrosis 
are the conditions that responsible in the formation 
of the wave.6-9 A study found that the width of the 
baseline Q-wave in STEMI has a prognostic role in 
predicting 90-day mortality, congestive heart failure, or 
cardiogenic shock, the prognosis was worsened as the 
width increased.11
 Another study shows that subjects with pathological 
Q wave on presentation were more frequently male, 
had higher heart rates, more advanced Killip class and 
had a longer time from the onset of symptoms to PCI. 
Subject with pathological Q wave had higher 1-year all-
cause mortality than subjects without the wave (baseline 
Q waves: 4.9%; no baseline Q waves: 2.8%; hazard 
ratio=1.78, 95% CI:1.29 to 2.45, p<0.001).20  The 
presence of Q waves on baseline ECG was associated 
with higher 90-day mortality in men (hazard ratio=1.7, 
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95% CI:1.0 to 2.7) and women (hazard ratio=2.3, 95% 
CI:1.2 to 4.2), the pathological Q wave was a better 
marker of risk than symptom onset to PCI.21
 GRACE score is a risk stratification score that 
has good performance for prognosis stratification for 
ACS patient, ESC recommends the use of this score 
for ACS include STEMI patients.1,5 A study from 
Myocardial Infarction National Audit Project (MINAP) 
database shows that the performances of GRACE score 
are AUC=0.80 (95% CI:0.80 to 0.81) for in-hospital 
mortality, and AUC=0.80 (95% CI:0.79 to 0.80) for 
6-month mortality.22 In relation to hospital death, one 
study shows the performance of the GRACE score was 
AUC=0.87 (95% CI:0.75 to 0.99).23 GRACE score 
performance in another study was similar to our study 
with AUC=0.83 (95% CI:0.79 to 0.87), the endpoints 
of the study were cardiac death, AMI and unstable 
angina within 30-day.24
 GRACE score has several components to 
measure, include the ST-deviation. The score only 
has dichotomous value for the ST-deviation not the 
quantitative measurement of deviation. This study 
found that the degree of deviation has comparable 
performance. Highest STE amplitude has the best 
performance than the other ECG characteristics and 
comparable with GRACE score, with high specificity 
in cut off point 4.5mm whom acceptable for “rule in” 
criteria for clinical practice.
Limitations
For the purpose of better generalization to the 
population, we use only “immediate ECG measurement 
on admission” and not restricting with symptom onset, 
delay of treatment may confound the prognosis of the 
patient, but the variability in the onset may be the one 
that responsible in the variability of ECG characteristics. 
Also, this study was single-center study and the subjects 
were relatively small, the variability of the center 
protocol may affect the patient prognosis.
Conclusions
In conclusion, quantitative ECG characteristics have 
comparable prognostic value with GRACE score and 
good performance as mortality predictor, especially 
highest STE amplitude. Quantitative measurement of 
the waves may add the performance of the novel risk 
stratification scoring. Future study will be needed to 
including the quantitative measurement of ECG to 
prognosis scoring system.
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List of Abbreviations
ACS=acute coronary syndrome
AMI=acute myocardial infarction
Table 3. Electrocardiogram characteristics between the non-
survivor and survivor group
Non-survivor
(n=9)
Survivor
(n=48) p-value
Number lead with 
STE, lead
3(3, 5) 4(3, 4) 0.925
Highest STE 
amplitude, mm
5(3, 5) 3(3, 4) 0.002
Total STE 
amplitude, mm
13(8, 20) 10(7, 12) 0.030
Number lead with 
Q, lead
3(1, 3) 2(0, 3) 0.044
Deepest Q 
amplitude, mm
4(1, 4) 2(0, 2) 0.003
Total Q amplitude, 
mm
9(3, 10) 4(0, 6) 0.005
STE=ST-segment elevation; all characteristics are presented as 
median(25th percentile, 75th percentile) and compared using 
Mann-Whitney test
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AUC=area under the curve
CI=confidence interval
ECG=electrocardiogram
ESC=European Society of Cardiology
GRACE=Global Registry of Acute Coronary Events
LVEF=left ventricular ejection fraction
MINAP=Myocardial Infarction National Audit Project
PCI=percutaneous coronary intervention
ROC=receiver operating characteristic 
STE=ST-segment elevation
STEMI=ST-elevation myocardial infarction
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